Apex Biotechnology Corp. (1733.TW)
TWD 32.3
(2.05%)
TWD 32.3
(2.05%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.16 TWD | -36.26% |
| 2022 | 1.82 TWD | -10.34% |
| 2021 | 2.03 TWD | 113.68% |
| 2020 | 0.95 TWD | -16.67% |
| 2019 | 1.14 TWD | 34.12% |
| 2018 | 0.85 TWD | -1.16% |
| 2017 | 0.86 TWD | 2766.67% |
| 2016 | 0.03 TWD | -98.87% |
| 2015 | 2.66 TWD | -3.97% |
| 2014 | 2.77 TWD | -26.53% |
| 2013 | 3.77 TWD | -30.31% |
| 2012 | 5.41 TWD | -1.81% |
| 2011 | 5.51 TWD | 16.24% |
| 2010 | 4.74 TWD | 39.0% |
| 2009 | 3.41 TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.27 TWD | -6.9% |
| 2024 Q1 | 0.29 TWD | 93.33% |
| 2023 Q4 | 0.15 TWD | -60.53% |
| 2023 Q2 | 0.27 TWD | -25.0% |
| 2023 FY | - TWD | -36.26% |
| 2023 Q1 | 0.36 TWD | -16.28% |
| 2023 Q3 | 0.38 TWD | 40.74% |
| 2022 Q3 | 0.64 TWD | 120.69% |
| 2022 FY | - TWD | -10.34% |
| 2022 Q1 | 0.46 TWD | -54.46% |
| 2022 Q4 | 0.43 TWD | -32.81% |
| 2022 Q2 | 0.29 TWD | -36.96% |
| 2021 FY | - TWD | 113.68% |
| 2021 Q3 | 0.64 TWD | 178.26% |
| 2021 Q1 | 0.34 TWD | 3.03% |
| 2021 Q4 | 1.01 TWD | 57.81% |
| 2021 Q2 | 0.23 TWD | -32.35% |
| 2020 Q2 | 0.27 TWD | 125.0% |
| 2020 Q1 | 0.12 TWD | -85.54% |
| 2020 Q4 | 0.33 TWD | 43.48% |
| 2020 FY | - TWD | -16.67% |
| 2020 Q3 | 0.23 TWD | -14.81% |
| 2019 Q3 | -0.17 TWD | -160.71% |
| 2019 FY | - TWD | 34.12% |
| 2019 Q1 | 0.22 TWD | 159.46% |
| 2019 Q2 | 0.28 TWD | 27.27% |
| 2019 Q4 | 0.83 TWD | 588.24% |
| 2018 Q2 | 0.45 TWD | 164.71% |
| 2018 FY | - TWD | -1.16% |
| 2018 Q3 | 0.71 TWD | 57.78% |
| 2018 Q1 | 0.17 TWD | -61.36% |
| 2018 Q4 | -0.37 TWD | -152.11% |
| 2017 Q4 | 0.44 TWD | 100.0% |
| 2017 Q1 | -0.39 TWD | 62.5% |
| 2017 Q3 | 0.22 TWD | -62.07% |
| 2017 FY | - TWD | 2766.67% |
| 2017 Q2 | 0.58 TWD | 248.72% |
| 2016 Q4 | -1.04 TWD | -10500.0% |
| 2016 FY | - TWD | -98.87% |
| 2016 Q1 | 0.68 TWD | -11.69% |
| 2016 Q2 | 0.65 TWD | -4.41% |
| 2016 Q3 | 0.01 TWD | -98.46% |
| 2015 Q3 | 1.11 TWD | 170.73% |
| 2015 FY | - TWD | -3.97% |
| 2015 Q1 | 0.37 TWD | -56.47% |
| 2015 Q2 | 0.41 TWD | 10.81% |
| 2015 Q4 | 0.77 TWD | -30.63% |
| 2014 Q1 | 0.63 TWD | 103.23% |
| 2014 Q4 | 0.85 TWD | 34.92% |
| 2014 Q3 | 0.63 TWD | -3.08% |
| 2014 Q2 | 0.65 TWD | 3.17% |
| 2014 FY | - TWD | -26.53% |
| 2013 Q3 | 0.52 TWD | -68.67% |
| 2013 Q4 | 0.31 TWD | -40.38% |
| 2013 FY | - TWD | -30.31% |
| 2013 Q1 | 1.28 TWD | -0.78% |
| 2013 Q2 | 1.66 TWD | 29.69% |
| 2012 Q2 | 1.53 TWD | 4.08% |
| 2012 FY | - TWD | -1.81% |
| 2012 Q3 | 1.11 TWD | -27.45% |
| 2012 Q1 | 1.47 TWD | -3.29% |
| 2012 Q4 | 1.29 TWD | 16.22% |
| 2011 Q4 | 1.52 TWD | -16.48% |
| 2011 Q1 | 1.02 TWD | 7.37% |
| 2011 Q3 | 1.82 TWD | 58.26% |
| 2011 FY | - TWD | 16.24% |
| 2011 Q2 | 1.15 TWD | 12.75% |
| 2010 Q2 | 1.30 TWD | 15.04% |
| 2010 Q4 | 0.95 TWD | -30.66% |
| 2010 Q1 | 1.13 TWD | 0.0% |
| 2010 FY | - TWD | 39.0% |
| 2010 Q3 | 1.37 TWD | 5.38% |
| 2009 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Sinphar Pharmaceutical Co.,Ltd. | 2.24 TWD | 48.214% |
| Panion & Bf Biotech Inc. | 0.90 TWD | -28.889% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 3.42 TWD | 66.082% |
| GenMont Biotech Incorporation | 0.38 TWD | -205.263% |
| Abnova (Taiwan) Corporation | 0.72 TWD | -61.111% |
| Adimmune Corporation | -1.52 TWD | 176.316% |
| Tanvex BioPharma, Inc. | -16.42 TWD | 107.065% |
| Polaris Group | -2.12 TWD | 154.717% |
| Energenesis Biomedical CO.,LTD. | -3.62 TWD | 132.044% |
| UnicoCell Biomed Co., Ltd. | -1.56 TWD | 174.359% |
| PELL Bio-Med Technology Co. Ltd. | -8.62 TWD | 113.457% |